ARCHIVES

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013

Congress Hasn’t Completed Action Yet On Major Health Bills; Reauthorization Fight In 1988-89

July 17, 1987

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975